WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S.

Moderna's novel vaccine was at the center of dustup with agency earlier this year

Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.

U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic.

U.S. health advisers are debating a new kind of flu vaccine

Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and up

The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.

WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S.

Un comit� de asesores independientes de la Administraci�n de Alimentos y Medicamentos de Estados Unidos (FDA, en sus siglas inglesas) recomienda la aprobaci�n de la primera...

Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.